LACEY FATER: Open Payments
NPI 1619495454 · SEA CLIFF, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 67 payments from 11 companies in 2025. Trend: 2023 $937 · 2024 $1,476 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $217 |
| Merck Sharp & Dohme LLC | 9 | $168 |
| Amgen Inc. | 9 | $156 |
| Esperion Therapeutics, Inc. | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| Novo Nordisk Inc | 3 | $76 |
| Boston Scientific Corporation | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: LEQVIO, VERQUVO, REPATHA, NEXLETOL, JARDIANCE, WATCHMAN FLX, Rybelsus, FARXIGA.
Industry payments across NY — which companies pay providers there.
